- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 376
Aro Biotherapeutics hits $88m series A target
Ionis Pharmaceuticals and Johnson & Johnson Innovation – JJDC were among the investors in a round that will fund development of Aro's centyrin-RNA conjugate medicines.
Jan 5, 2021Katerra catches $200m from SoftBank
The corporate will get a majority stake in end-to-end construction services provider Katerra, helping it avoid bankruptcy protection.
Jan 4, 202123andme passes series F test
The Alphabet, GSK, WuXi AppTec, Johnson & Johnson, Roche and Illumina-backed genetic testing service has now raised over $870m altogether.
Jan 4, 2021Kymeta secures $30m Hanwha investment
Hanwha Systems has agreed to provide $30m in funding for the satellite technology provider, whose existing investors include Liberty Global and Intelsat.
Jan 4, 2021US sports teams add diversity to investments
The Green Bay Packers, Milwaukee Bucks and Milwaukee Brewers joined Microsoft in backing an impact investment arm of venture capital fund TitletownTech.
Jan 4, 2021Hayes and Gimenez promoted to managing partner at BP
Restructure at BP follows Meghan Sharp's return as global head of ventures.
Jan 4, 2021Corporate venturing deal net: 21-31 December 2020
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
Dec 31, 2020Deal net: December 18 to 31, 2020
Today’s deal net round ups the smaller investments from across the university innovation ecosystem that have occurred over the holiday period.
Dec 31, 2020Flexiv assembles $100m series B
Investors have thrown their backing behind a round topping $100m for Stanford-linked production automation robot developer Flexiv.
Dec 31, 2020Graphcore grafts on $222m
The intelligent chipmaker, which counts Microsoft, Samsung, BMW, Robert Bosch and Dell as investors, secured series E funding at a $2.77bn valuation.
Dec 30, 2020About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


